Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Meetu Bhogal"'
Autor:
Werner J. Becker, Guy Boudreau, Ian Finkelstein, Corrie Graboski, May Ong, Suzanne Christie, Katherine Sommer, Meetu Bhogal, Goran Davidovic
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50:418-427
Background:PREDICT was a Canadian, multicenter, prospective, observational study in adults naïve to onabotulinumtoxinA treatment for chronic migraine (CM). We descriptively assess health resource utilization, work productivity, and acute medication
Autor:
Katherine Sommer, Goran Davidovic, May Ong, Werner J. Becker, Meetu Bhogal, Guy P Boudreau, Corrie Graboski, Ian Finkelstein, Suzanne N. Christie
Publikováno v:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 49(4)
Background:The PREDICT study assessed real-world, long-term health-related quality of life in adults with chronic migraine (CM) receiving onabotulinumtoxinA.Methods:Canadian, multicenter, prospective, observational study in adults naïve to onabotuli
Autor:
Martin Cloutier, Mélanie Langlois, Pierre Naud, Goran Davidovic, Marc Petitclerc, Meetu Bhogal
Publikováno v:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Introduction:Symptoms of cervical dystonia (CD) can vary in severity and cause significant pain. OnabotulinumtoxinA is an approved treatment for CD. This study assessed health-related quality of life (HRQoL) in patients with CD who received multiple
Autor:
Mandar Jog, Robert M. Miller, Theodore Wein, Farooq Ismail, Richard D. Beauchamp, Grace Trentin, Sonja Dhani, Meetu Bhogal
Publikováno v:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 46(6)
Although therapeutic treatments are intended to help alleviate symptoms associated with disease, safety must be carefully considered and monitored to confirm continued positive benefit/risk balance. The objective of MOBILITY was to study the long-ter
Autor:
Farooq Ismail, Theodore Wein, Grace Trentin, Mandar Jog, Richard D. Beauchamp, Robert M. Miller, Sonja Dhani, Meetu Bhogal
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43:687-696
Background:OnabotulinumtoxinA is an efficacious treatment option for patients with various conditions. Although studies have reported on the efficacy of onabotulinumtoxinA, quality of life (QoL) data are limited. This study evaluated QoL in patients
Autor:
Nowell Solish, Chris Somogyi, Channy Muhn, Xiaofang Lei, Meetu Bhogal, Carrie A. Caulkins, Shannon Humphrey, Jason K. Rivers
Publikováno v:
Dermatologic Surgery. 42:410-419
BACKGROUND Various onabotulinumtoxinA doses are effective in treating forehead lines (FHL), with a trend toward lower doses. OBJECTIVE To evaluate efficacy and safety of onabotulinumtoxinA dose-ranging treatment of FHL when the frontalis area and gla
Publikováno v:
Aesthetic surgery journal. 39(12)
Background Reoperation after primary breast augmentation remains an important clinical issue. Objective The authors sought to evaluate incidence and causes of reoperation in patients who underwent primary augmentation. Methods This retrospective, non
Autor:
Suzanne N. Christie, Corrie Graboski, Guy P Boudreau, M Ong-Lam, Ian Finkelstein, Werner J. Becker, Meetu Bhogal, Goran Davidovic
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 46:S16
Background: We assessed long-term health-related quality of life (HRQoL) and functioning in adults receiving onabotulinumtoxinA for CM. Methods: Interim analysis of multicentre, prospective, observational study in adults naïve to botulinum toxin (NC
Autor:
Christopher S Sigouin, Marino Discepola, Donald R Nixon, David Yan, Susan Simonyi, Cindy M.L. Hutnik, Meetu Bhogal, Andrew Crichton
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Donald R Nixon,1 Susan Simonyi,2 Meetu Bhogal,2 Christopher S Sigouin,3 Andrew C Crichton,4 Marino Discepola,5 Cindy ML Hutnik,6 David B Yan71Private Practice, Barrie, ON, 2Allergan Inc, Markham, ON, 3CLINWest Research, Burlington, ON, 4University of
Publikováno v:
Value in Health. 19:A66-A67